| Enhancer ID: | E_01_0876 |
| Species: | human |
| Position : | chr2:25730681-25732681 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Colorectal cancer |
| Pubmed ID: | 33116876 |
| Enhancer experiment: | Quantitative real-time polymerase chain reaction (QRT PCR), Western blot analysis and immunohistochemistry (IHC) |
| Enhancer experiment description: | These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
| Target gene : | -- |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
| TF name : | ASXL2 |
| TF experiment: | ???????????qRT-PCR???????????????IHC? |
| TF experiment description: | These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
| Enhancer function : | These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
These results showed that ASXL2 could induce cell proliferation, which was associated with poor prognosis of CRC patients, suggesting that ASXL2 might be a new therapeutic target for CRC. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|